![](/images/graphics-bg.png)
Intravenous remifentanil analgaesia for an obstetric patient with type i neurofibromatosis and a factor v leiden mutation
Other Title(s)
التسكين بالراميفنتانيل الوريدي لمريضة في مرحلة الولادة مصابة بالنوع 1 من الورم الليفي العصبي و العامل الخامس لطفرة ليدن
Joint Authors
Gálvez, José L.
Errando, Carlos L.
Serrano, Silvia
Martín Ayuso, Marga
Valverde Mantecón, José M.
Source
Sultan Qaboos University Medical Journal
Issue
Vol. 17, Issue 4 (30 Nov. 2017), pp.468-471, 4 p.
Publisher
Sultan Qaboos University College of Medicine and Health Sciences
Publication Date
2017-11-30
Country of Publication
Oman
No. of Pages
4
Main Subjects
Abstract EN
Type I neurofibromatosis is characterised by altered skin pigmentation and the growth of benign tumours, particularly along the peripheral nerves and central nervous system.
We report a 36-year-old primigravida woman in labour who was admitted to the obstetric suite of the Hospital Sant Joan de Déu, Barcelona, Spain, in 2007 with hypothyroidism, type I neurofibromatosis and a factor V Leiden mutation.
Due to a lack of cranial and spinal imaging data, an epidural was not indicated; instead, continuous intravenous remifentanil analgaesia was administered.
The remifentanil infusion was self-titrated by the patient using a visual analogue scale, with the dosage ranging from 0.01 to 0.25 μg/kg/minute.
Due to rotational dystocia, Kjelland-type forceps were used during the delivery.
After birth, the infant was found to have Apgar scores of 9 and 10, with no maternal or neonatal adverse effects observed.
Although still controversial, remifentanil may be a successful alternative for analgaesia in similar cases; however, the specific risks and benefits for each patient should be considered prior to administration.
American Psychological Association (APA)
Gálvez, José L.& Errando, Carlos L.& Serrano, Silvia& Martín Ayuso, Marga& Valverde Mantecón, José M.. 2017. Intravenous remifentanil analgaesia for an obstetric patient with type i neurofibromatosis and a factor v leiden mutation. Sultan Qaboos University Medical Journal،Vol. 17, no. 4, pp.468-471.
https://search.emarefa.net/detail/BIM-799386
Modern Language Association (MLA)
Gálvez, José L.…[et al.]. Intravenous remifentanil analgaesia for an obstetric patient with type i neurofibromatosis and a factor v leiden mutation. Sultan Qaboos University Medical Journal Vol. 17, no. 4 (Nov. 2017), pp.468-471.
https://search.emarefa.net/detail/BIM-799386
American Medical Association (AMA)
Gálvez, José L.& Errando, Carlos L.& Serrano, Silvia& Martín Ayuso, Marga& Valverde Mantecón, José M.. Intravenous remifentanil analgaesia for an obstetric patient with type i neurofibromatosis and a factor v leiden mutation. Sultan Qaboos University Medical Journal. 2017. Vol. 17, no. 4, pp.468-471.
https://search.emarefa.net/detail/BIM-799386
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references : p. 470-471
Record ID
BIM-799386